Sustainability | September 28, 2024
Amcor's long-term SBTi targets confirmed
The net-zero target approval complements the company's near-term emission reduction targets
The net-zero target approval complements the company's near-term emission reduction targets
Dupixent is indicated for the approximately 300,000 adults in the US with inadequately controlled COPD and an eosinophilic phenotype
NMC to continue its efforts to improve and enhance the quality of medical education in the country
The raised capital enables Medix Biochemica to continue execution of inorganic growth initiatives
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
This case is an isolated case, similar to the earlier 30 cases reported in India from July 2022 onwards
TROPION-Lung01, evaluating AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan versus chemotherapy, previously met the dual primary endpoint of progression-free survival in the overall trial population
The collaborations will help curate industry focused courses such as Advanced Certification courses for healthcare professionals in Healthcare Marketing, Healthcare Technology and Specialized Clinical Fellowship Level programs with university accreditation
Subscribe To Our Newsletter & Stay Updated
